ClinicalTrials.Veeva

Menu

Does Pancreatic Stent Decrease the Risk of Pancreatitis After Pancreatic Sphincterotomy for Difficult Cannulation?

H

Helsinki University Central Hospital (HUCH)

Status

Enrolling

Conditions

Endoscopic Retrograde Cholangiopancreatography

Treatments

Device: Biliary cannulation

Study type

Interventional

Funder types

Other

Identifiers

NCT04408482
3509/2019

Details and patient eligibility

About

The purpose of the study is to compare the risk of PEP after pancreatic sphincterotomy performed for difficult cannulation in a group of patients with and in a group of patients without placement of a prophylactic pancreatic stent. The definition of difficult cannulation is defined according to the literature.

Enrollment

268 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Consecutive patients with naïve papilla presenting to ERCP with indication of common bile duct (CBD) cannulation will be considered to the study.

Exclusion criteria

  • Exclusion criteria are age below 18 years, acute pancreatitis and no consent to the study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

268 participants in 2 patient groups

Pancreatic sphincterotomy
Active Comparator group
Description:
Pancreatic sphincterotomy performed in difficult cannulation
Treatment:
Device: Biliary cannulation
Pancreatic sphincterotomy + pancreatic stent
Active Comparator group
Description:
Pancreatic sphincterotomy performed in difficult cannulation + pancreatic stent placement
Treatment:
Device: Biliary cannulation

Trial contacts and locations

1

Loading...

Central trial contact

Andrea Tenca, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems